| 2026-08-21 17:30 |
8-K |
["7.01", "9.01"] |
other |
0.05
|
8-K announces opening of new testing/treatment facility; no M&A signals present. |
SEC · detail |
| 2026-08-11 17:02 |
8-K |
["7.01", "9.01"] |
other |
0.05
|
Patent issuance announcement; no M&A relevance detected. |
SEC · detail |
| 2026-08-03 17:29 |
8-K |
["1.01", "5.02"] |
officer change |
0.35
|
CFO resignation and replacement with external advisor; no M&A language or strategic review signals. |
SEC · detail |
| 2026-07-07 17:29 |
8-K |
["1.01"] |
material agreement |
0.15
|
PIPE financing agreement with existing shareholder; no M&A or acquisition signals present. |
SEC · detail |
| 2026-06-25 17:22 |
8-K |
["1.01", "7.01", "9.01"] |
material agreement |
0.15
|
Debt-to-equity exchange agreement with creditor; financing deadline extension. No M&A signal. |
SEC · detail |
| 2026-06-16 17:03 |
8-K |
["8.01", "9.01"] |
other |
0.05
|
Rights offering announcement; no M&A or acquisition signals present. |
SEC · detail |
| 2026-06-15 19:44 |
8-K |
["1.01", "7.01", "9.01"] |
material agreement |
0.15
|
Vivos enters collaboration to form MSO with SPCVA for sleep apnea services; not M&A-related. |
SEC · detail |
| 2026-06-08 08:30 |
8-K |
["1.01"] |
material agreement |
0.15
|
Debt restructuring and equity financing arrangements with lenders; no M&A or acquisition signals. |
SEC · detail |